BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28283733)

  • 1. High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.
    Alberdi-Saugstrup M; Zak M; Nielsen S; Herlin T; Nordal E; Berntson L; Fasth A; Rygg M; Klaus Müller ;
    Rheumatol Int; 2017 May; 37(5):695-703. PubMed ID: 28283733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low pretreatment levels of myeloid-related protein-8/14 and C-reactive protein predict poor adherence to treatment with tumor necrosis factor inhibitors in juvenile idiopathic arthritis.
    Alberdi-Saugstrup M; Nielsen S; Mathiessen P; Nielsen CH; Müller K
    Clin Rheumatol; 2017 Jan; 36(1):67-75. PubMed ID: 27562034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the Juvenile Arthritis Disease Activity Score based on erythrocyte sedimentation rate or C-reactive protein level: results from the Portuguese register.
    Mourão AF; Santos MJ; Melo-Gomes J; Martins FM; Costa JA; Ramos F; Brito I; Duarte C; Figueira R; Figueiredo G; Furtado C; Lopes A; Oliveira M; Rodrigues A; Salgado M; Sousa M; Branco JC; Fonseca JE; Canhão H
    Arthritis Care Res (Hoboken); 2014 Apr; 66(4):585-91. PubMed ID: 25354266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study.
    Tappeiner C; Klotsche J; Sengler C; Niewerth M; Liedmann I; Walscheid K; Lavric M; Foell D; Minden K; Heiligenhaus A
    Arthritis Rheumatol; 2018 Oct; 70(10):1685-1694. PubMed ID: 29732713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based setting.
    Nordal EB; Zak M; Aalto K; Berntson L; Fasth A; Herlin T; Lahdenne P; Nielsen S; Peltoniemi S; Straume B; Rygg M
    Ann Rheum Dis; 2012 Jul; 71(7):1122-7. PubMed ID: 22258487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory Markers and Disease Activity in Juvenile Idiopathic Arthritis.
    Sarkar S; Alam MM; Das G; Datta S
    Indian J Pediatr; 2017 May; 84(5):349-356. PubMed ID: 28176230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of selected biomarkers, polymorphisms, and clinical features for oligoarticular juvenile idiopathic arthritis-associated uveitis.
    Pelegrín L; Casaroli-Marano R; Antón J; García de Vicuña MC; Molina-Prat N; Ignacio Aróstegui J; Yagüe J; Ríos J; Adán A
    Ocul Immunol Inflamm; 2014 Jun; 22(3):208-12. PubMed ID: 24131380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline.
    Ganeva M; Fuehner S; Kessel C; Klotsche J; Niewerth M; Minden K; Foell D; Hinze CH; Wittkowski H
    Pediatr Rheumatol Online J; 2021 May; 19(1):64. PubMed ID: 33933108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of neopterin as a marker of immune system activation and juvenile rheumatoid arthritis activity.
    Shady MM; Fathy HA; Ali A; Youness ER; Fathy GA
    J Pediatr (Rio J); 2015; 91(4):352-7. PubMed ID: 25727025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in juvenile rheumatoid arthritis.
    Wu JF; Yang YH; Wang LC; Lee JH; Shen EY; Chiang BL
    Clin Exp Rheumatol; 2007; 25(5):782-5. PubMed ID: 18078633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Power Doppler ultrasonography in comparison with biological markers in the evaluation of disease activity in Juvenile Idiopathic Arthritis.
    Spârchez M; Fodor D; Miu N
    Med Ultrason; 2010 Jun; 12(2):97-103. PubMed ID: 21173935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of biomarkers in juvenile idiopathic arthritis patients and their significant association with disease severity: a comparative study.
    Gilliam BE; Chauhan AK; Low JM; Moore TL
    Clin Exp Rheumatol; 2008; 26(3):492-7. PubMed ID: 18578976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and long-term outcome in Greek adults with juvenile idiopathic arthritis: a 17-year continuous follow-up study.
    Dimopoulou D; Trachana M; Pratsidou-Gertsi P; Sidiropoulos P; Kanakoudi-Tsakalidou F; Dimitroulas T; Garyfallos A
    Rheumatology (Oxford); 2017 Nov; 56(11):1928-1938. PubMed ID: 29088453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis.
    Haasnoot AJ; van Tent-Hoeve M; Wulffraat NM; Schalij-Delfos NE; Los LI; Armbrust W; Zuithoff NP; de Boer JH
    Am J Ophthalmol; 2015 Feb; 159(2):372-7.e1. PubMed ID: 25447121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis.
    Cantarini L; Giani T; Fioravanti A; Iacoponi F; Simonini G; Pagnini I; Spreafico A; Chellini F; Galeazzi M; Cimaz R
    Yonsei Med J; 2012 Sep; 53(5):1045-8. PubMed ID: 22869491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein in the assessment of disease activity in juvenile rheumatoid arthritis and juvenile spondyloarthritis.
    Hussein A; Stein J; Ehrich JH
    Scand J Rheumatol; 1987; 16(2):101-5. PubMed ID: 3602941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.
    Pelkmans LG; Aarnoudse AJ; Hendriksz TR; van Bommel EF
    Nephrol Dial Transplant; 2012 Jul; 27(7):2819-25. PubMed ID: 22273666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8/14 protein.
    Moncrieffe H; Ursu S; Holzinger D; Patrick F; Kassoumeri L; Wade A; Roth J; Wedderburn LR
    Rheumatology (Oxford); 2013 Aug; 52(8):1467-76. PubMed ID: 23620557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort.
    Glerup M; Thiel S; Rypdal V; Arnstad ED; Ekelund M; Peltoniemi S; Aalto K; Rygg M; Nielsen S; Fasth A; Berntson L; Nordal E; Herlin T;
    Pediatr Rheumatol Online J; 2019 Sep; 17(1):63. PubMed ID: 31500626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis.
    Selvaag AM; Aulie HA; Lilleby V; Flatø B
    Ann Rheum Dis; 2016 Jan; 75(1):190-5. PubMed ID: 25362042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.